Day: May 19, 2023
SHANGHAI, China, May 18, 2023 (GLOBE NEWSWIRE) — Xiao-I Corporation (Nasdaq: AIXI) (“Xiao-I” or the “Company”), a leading cognitive artificial intelligence (“AI”) enterprise in China, today announced the launch of its state-of-the-art Intelligent Document Processing (“IDP”) product. This innovative solution is delivered by a smart and efficient platform that streamlines and automates the document management process, empowering businesses towards an era of intelligent operations.
In the fast-paced landscape of digital transformation, enterprises frequently grapple with an overwhelming volume of documents, intricate document types, and inefficiency in manual information processing. Xiao-I’s IDP solution addresses these challenges by providing automated document recognition, classification, and key information extraction to...
Ipsen and Marengo Therapeutics announce strategic partnership to advance two precision immuno-oncology candidates from Marengo’s STAR Platform into the clinic
Written by Customer Service on . Posted in Public Companies.
Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation approach
Ipsen to pay Marengo $45 million upfront with potential for additional milestone paymentsPARIS, FRANCE & CAMBRIDGE, MASSACHUSETTS, 01 August, 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and Marengo Therapeutics, Inc. today announced a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic. The collaboration will leverage Marengo’s proprietary R&D expertise of a novel mechanism of T cell activation with Ipsen’s global oncology footprint for clinical development and commercialization.
Under the terms of the agreement, Ipsen will make an upfront payment of $45 million, together with potential payments up to a total...